[
  {
    "MMSE score between 22 and 30": "Positive amyloid PET scan",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "ImagingStudy",
    "LOINC: 72107-6": "SNOMED: 441652000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Amyloid PET imaging revealed elevated amyloid deposition."
  },
  {
    "MMSE score between 22 and 30": "Clinical Dementia Rating (CDR) score of 0.5 to 1.0",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cognitive Assessment",
    "83.3%": "75.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 54626-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "CDR score was assessed as 0.5 indicating very mild dementia."
  },
  {
    "MMSE score between 22 and 30": "Apolipoprotein E (ApoE) genotyping",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Genetic",
    "83.3%": "41.7%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 21641-9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient consented to ApoE genetic testing for AD risk."
  },
  {
    "MMSE score between 22 and 30": "Uncontrolled hypertension",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I10",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Hypertension not managed with medication, BP >170/100."
  },
  {
    "MMSE score between 22 and 30": "Significant cerebrovascular disease",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I67.89",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MRI indicates evidence of chronic cerebrovascular ischemia."
  },
  {
    "MMSE score between 22 and 30": "Stable use of symptomatic AD medications",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 430193006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient has been on donepezil 10mg for over 3 months."
  },
  {
    "MMSE score between 22 and 30": "History of stroke or TIA within 1 year",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "58.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I63.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient had a minor stroke 8 months ago."
  },
  {
    "MMSE score between 22 and 30": "Study partner available for the duration of the trial",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Caregiver/Support",
    "83.3%": "91.7%",
    "Inclusion": "Inclusion",
    "Observation": "RelatedPerson",
    "LOINC: 72107-6": "SNOMED: 224291000000109",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient's spouse agreed to accompany them to all clinic visits as study partner."
  },
  {
    "MMSE score between 22 and 30": "History of psychiatric illness (e.g., major depression, psychosis)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "83.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F33.1",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient had a diagnosis of major depressive disorder 6 months ago."
  },
  {
    "MMSE score between 22 and 30": "Contraindications to MRI (e.g., metal implants, pacemakers)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "75.0%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 433146000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MRI contraindicated due to presence of pacemaker."
  },
  {
    "MMSE score between 22 and 30": "Evidence of abnormal liver or renal function",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 24323-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Elevated liver enzymes noted in baseline labs."
  },
  {
    "MMSE score between 22 and 30": "History of alcohol or substance abuse in past 1\u20132 years",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Lifestyle Factors",
    "83.3%": "75.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F10.10",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient reports alcohol dependence until last year."
  },
  {
    "MMSE score between 22 and 30": "Use of investigational drug within past 6 months",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "58.3%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Subject previously enrolled in trial involving investigational BACE inhibitor."
  },
  {
    "MMSE score between 22 and 30": "Adequate vision and hearing to complete assessments",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Functional Status",
    "83.3%": "41.7%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 397540003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Hearing and visual acuity adequate for neuropsych testing."
  },
  {
    "MMSE score between 22 and 30": "Pregnant or breastfeeding",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Reproductive",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 11449-6",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Pregnancy test positive at baseline screening."
  },
  {
    "MMSE score between 22 and 30": "Age between 50 and 90 years",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Demographics",
    "83.3%": "83.3%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "SNOMED: 397669002",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient is 72 years old at time of screening."
  },
  {
    "MMSE score between 22 and 30": "Diagnosis of probable Alzheimer's Disease or MCI due to AD",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "91.7%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "SNOMED: 26929004",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Clinical diagnosis of mild cognitive impairment due to Alzheimer\u2019s Disease."
  },
  {
    "MMSE score between 22 and 30": "Abnormal memory function (e.g., WMS-R LM II or equivalent)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cognitive Assessment",
    "83.3%": "75.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 72106-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Logical Memory II recall score was below normal range for age."
  },
  {
    "MMSE score between 22 and 30": "Participation in another monoclonal antibody therapy trial",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Previously enrolled in a monoclonal antibody trial targeting amyloid."
  },
  {
    "MMSE score between 22 and 30": "Stable dose of Alzheimer\u2019s medications for at least 8\u201312 weeks",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 430193006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "On donepezil 10mg for past 3 months without dose change."
  },
  {
    "MMSE score between 22 and 30": "Positive biomarker for brain amyloid pathology (PET/CSF/plasma)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Biomarker",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 441652000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "CSF A\u03b242 levels below threshold consistent with AD pathology."
  },
  {
    "MMSE score between 22 and 30": "Major systemic illness not under control (cardiac, hepatic, renal)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "58.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: R69",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient has poorly controlled heart failure with recent hospitalization."
  },
  {
    "MMSE score between 22 and 30": "Body Mass Index (BMI) between 17 and 35",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Vitals",
    "83.3%": "33.3%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 39156-5",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "BMI calculated at 26.7 during screening visit."
  },
  {
    "MMSE score between 22 and 30": "No other neurodegenerative diseases (e.g., Parkinson\u2019s, Huntington\u2019s)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "66.7%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G20",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "History of Parkinson\u2019s disease ruled out at screening."
  },
  {
    "MMSE score between 22 and 30": "No evidence of intracranial mass or lesions (e.g., glioma, contusion)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "58.3%",
    "Inclusion": "Exclusion",
    "Observation": "ImagingStudy",
    "LOINC: 72107-6": "SNOMED: 271442000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Brain MRI showed no space-occupying lesions or tumors."
  },
  {
    "MMSE score between 22 and 30": "No history of seizures within past 12 months",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "41.7%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G40.909",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No seizures reported in last year."
  },
  {
    "MMSE score between 22 and 30": "No contraindicated medications (e.g., methyldopa, neuroleptics)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Medication History",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 182834006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient discontinued neuroleptics 6 weeks before screening."
  },
  {
    "MMSE score between 22 and 30": "No unstable cardiovascular disease (e.g., angina, CHF)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "66.7%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I50.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient has stable coronary artery disease and no recent angina."
  },
  {
    "MMSE score between 22 and 30": "Hamilton Depression Rating Scale \u2264 12",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Psychiatric Assessment",
    "83.3%": "25.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 89261-2",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "HAM-D score was 9 at baseline screening."
  },
  {
    "MMSE score between 22 and 30": "No history of clinically significant head trauma",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "41.7%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: S06.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No head trauma events noted in patient history."
  },
  {
    "MMSE score between 22 and 30": "Normal thyroid function",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "33.3%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 3016-3",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "TSH level was 2.0 uIU/mL, within normal range."
  },
  {
    "MMSE score between 22 and 30": "Informant confirms gradual memory decline over 6\u201312 months",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cognitive Assessment",
    "83.3%": "50.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 386806002",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Caregiver reports patient's memory has worsened over the past year."
  },
  {
    "MMSE score between 22 and 30": "No active infection or systemic illness in past 30 days",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "SNOMED: 87628006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No fevers, cough, or infections documented in past month."
  },
  {
    "MMSE score between 22 and 30": "Willing and able to comply with protocol procedures",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Behavioral/Compliance",
    "83.3%": "75.0%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "SNOMED: 722912009",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient and caregiver agreed to attend all follow-up visits."
  },
  {
    "MMSE score between 22 and 30": "Consent provided by participant or legal representative",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 32485007",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Written informed consent obtained from participant\u2019s legal guardian."
  },
  {
    "MMSE score between 22 and 30": "No vitamin B12 deficiency or clinically significant low levels",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2132-9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Vitamin B12 level was 550 pg/mL \u2014 within normal range."
  },
  {
    "MMSE score between 22 and 30": "Stable use of non-AD medications \u22654 weeks prior to baseline",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "41.7%",
    "Inclusion": "Inclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 419474003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Blood pressure meds stable for 6 weeks prior to screening."
  },
  {
    "MMSE score between 22 and 30": "No recent surgery requiring general anesthesia",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Surgical History",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 52734007",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No major surgery noted in past 3 months."
  },
  {
    "MMSE score between 22 and 30": "No suicidal ideation or recent psychiatric hospitalization",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "SNOMED: 19160003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No suicidal thoughts or psychiatric admission in last 6 months."
  },
  {
    "MMSE score between 22 and 30": "No brain hemorrhage or bleeding disorder",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I61.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MRI showed no signs of intracranial bleeding or hemorrhage."
  },
  {
    "MMSE score between 22 and 30": "No uncontrolled diabetes mellitus",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: E11.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "HbA1c was 10.2%; patient excluded due to uncontrolled diabetes."
  },
  {
    "MMSE score between 22 and 30": "No anticoagulation therapy other than low-dose aspirin",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Medication History",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428191000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient on warfarin\u2014excluded due to anticoagulant use."
  },
  {
    "MMSE score between 22 and 30": "No HIV infection",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: B20",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "HIV test negative at screening."
  },
  {
    "MMSE score between 22 and 30": "Females must not be breastfeeding",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Reproductive",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 63894-1",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Participant denied current breastfeeding during medical interview."
  },
  {
    "MMSE score between 22 and 30": "No evidence of ARIA-E on MRI",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "16.7%",
    "Inclusion": "Exclusion",
    "Observation": "ImagingStudy",
    "LOINC: 72107-6": "SNOMED: 248200007",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MRI at week 116 showed no ARIA-E or edema-like changes."
  },
  {
    "MMSE score between 22 and 30": "No major depression per DSM or GDS > 8",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Psychiatric Assessment",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 48535-2",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "GDS score of 9\u2014excluded due to depressive symptoms."
  },
  {
    "MMSE score between 22 and 30": "No use of systemic corticosteroids within 3 months",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Medication History",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 373994007",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Prednisone therapy ended 1 month ago\u2014exclusion criterion met."
  },
  {
    "MMSE score between 22 and 30": "Adequate premorbid intellectual functioning",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cognitive Assessment",
    "83.3%": "33.3%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 248234009",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Participant\u2019s premorbid IQ estimated to be in average range."
  },
  {
    "MMSE score between 22 and 30": "No participation in anti-amyloid immunotherapy trials",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "41.7%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 763760008",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Not previously enrolled in any anti-amyloid immunotherapy study."
  },
  {
    "MMSE score between 22 and 30": "No history of systemic cancer within last 5 years",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: C80.1",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No cancer treatment history reported within past 5 years."
  },
  {
    "MMSE score between 22 and 30": "No obstructive pulmonary disease or asthma",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: J44.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No history of COPD or reactive airway disease."
  },
  {
    "MMSE score between 22 and 30": "No significant gastrointestinal disorder (e.g., ulcers, bleeding)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: K25.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient denied any history of ulcer-related GI bleeding."
  },
  {
    "MMSE score between 22 and 30": "No known hypersensitivity to investigational treatment",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "AllergyIntolerance",
    "LOINC: 72107-6": "SNOMED: 420134006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No allergic reactions to monoclonal antibodies reported."
  },
  {
    "MMSE score between 22 and 30": "No lacunar infarcts in critical brain regions",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "ImagingStudy",
    "LOINC: 72107-6": "SNOMED: 274100004",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MRI showed no infarcts in thalamus or basal ganglia."
  },
  {
    "MMSE score between 22 and 30": "No exposure to lecanemab",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 1087911000119102",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Confirmed that subject was never dosed with lecanemab."
  },
  {
    "MMSE score between 22 and 30": "No current use of memantine",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Medication History",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 387287000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Memantine therapy stopped 3 months prior to screening."
  },
  {
    "MMSE score between 22 and 30": "No active suicidal ideation or attempt in past 6 months",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 6471006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No recent suicidal behavior or hospitalization recorded."
  },
  {
    "MMSE score between 22 and 30": "No hypersensitivity to monoclonal antibody treatments",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Allergy/Intolerance",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "AllergyIntolerance",
    "LOINC: 72107-6": "SNOMED: 91936005",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No allergic history to therapeutic antibodies like BAN2401."
  },
  {
    "MMSE score between 22 and 30": "No participation in investigational drug trials within 30 days",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Last investigational therapy ended more than 2 months ago."
  },
  {
    "MMSE score between 22 and 30": "No G6PD deficiency",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "16.7%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 32532-2",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "G6PD test result within normal reference range."
  },
  {
    "MMSE score between 22 and 30": "No acute respiratory failure",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "8.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: J96.00",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No history or symptoms of respiratory failure found."
  },
  {
    "MMSE score between 22 and 30": "No methemoglobinemia or sensitivity to methylthioninium",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Allergy/Intolerance",
    "83.3%": "8.3%",
    "Inclusion": "Exclusion",
    "Observation": "AllergyIntolerance",
    "LOINC: 72107-6": "SNOMED: 444075003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No prior methemoglobinemia or adverse reaction to methylene blue."
  },
  {
    "MMSE score between 22 and 30": "No clinically significant ECG abnormalities",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cardiac/Vitals",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 11524-6",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Baseline ECG within normal sinus rhythm and intervals."
  },
  {
    "MMSE score between 22 and 30": "Women of childbearing potential must use contraception",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Reproductive",
    "83.3%": "25.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 410942007",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient advised to use effective contraception during the study."
  },
  {
    "MMSE score between 22 and 30": "MRI must be free of significant lesions or abnormalities",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "41.7%",
    "Inclusion": "Inclusion",
    "Observation": "ImagingStudy",
    "LOINC: 72107-6": "SNOMED: 274100004",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MRI showed no clinically significant structural abnormalities."
  },
  {
    "MMSE score between 22 and 30": "No unstable hepatic or renal disease",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: K76.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Liver function stable; no evidence of active hepatic disease."
  },
  {
    "MMSE score between 22 and 30": "Completion of prior core study phase",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "16.7%",
    "Inclusion": "Inclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 386053000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Subject completed all visits in core phase before joining extension."
  },
  {
    "MMSE score between 22 and 30": "Absence of severe visual or hearing impairment",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Functional Status",
    "83.3%": "25.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 248234002",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Hearing and vision tested adequate for neuropsychological tasks."
  },
  {
    "MMSE score between 22 and 30": "Must have \u22651 study partner with weekly contact",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Caregiver/Support",
    "83.3%": "58.3%",
    "Inclusion": "Inclusion",
    "Observation": "RelatedPerson",
    "LOINC: 72107-6": "SNOMED: 224291000000109",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Participant\u2019s daughter lives with her and is available for visits."
  },
  {
    "MMSE score between 22 and 30": "No ongoing immunoglobulin or immunosuppressant therapy",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "33.3%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428731000124106",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No immunosuppressive therapy recorded in the past 6 months."
  },
  {
    "MMSE score between 22 and 30": "Subject must be fluent in study-approved language",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "16.7%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "SNOMED: 417163006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Participant fluent in English and passed language comprehension screening."
  },
  {
    "MMSE score between 22 and 30": "Subject must be ambulatory or mobile with aid",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Functional Status",
    "83.3%": "33.3%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 16584000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient is mobile with walker and able to attend study visits."
  },
  {
    "MMSE score between 22 and 30": "No ongoing substance abuse",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "41.7%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F19.10",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient has no reported alcohol or drug dependence in the past year."
  },
  {
    "MMSE score between 22 and 30": "No history of epilepsy or seizure disorder",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G40.909",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No reported episodes of seizures or epilepsy since childhood."
  },
  {
    "MMSE score between 22 and 30": "No severe heart failure (NYHA Class III/IV)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cardiac/Vitals",
    "83.3%": "16.7%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I50.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Heart failure classified as NYHA Class II, eligible for study."
  },
  {
    "MMSE score between 22 and 30": "No long QT syndrome or QTc > 470 ms",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cardiac/Vitals",
    "83.3%": "16.7%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 80288-6",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Baseline ECG QTc was 455 ms\u2014within allowed range."
  },
  {
    "MMSE score between 22 and 30": "No neurological condition other than AD",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "58.3%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G31.84",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No diagnosis of Parkinson\u2019s, stroke, or frontotemporal dementia."
  },
  {
    "MMSE score between 22 and 30": "No MRI contraindications (e.g., pacemaker, metal implants)",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "41.7%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 433146000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No pacemakers, clips, or implants found\u2014MRI safe to perform."
  },
  {
    "MMSE score between 22 and 30": "No clinically significant thyroid dysfunction",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 11579-0",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "TSH and free T4 were within normal limits."
  },
  {
    "MMSE score between 22 and 30": "Age \u2265 50 years",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Demographic",
    "83.3%": "91.7%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "LOINC: 30525-0",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient is 68 years old\u2014meets age eligibility criteria."
  },
  {
    "MMSE score between 22 and 30": "No current enrollment in other interventional trials",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 386053000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Not participating in any other active investigational study."
  },
  {
    "MMSE score between 22 and 30": "Willingness to undergo lumbar puncture or PET scan",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Procedure",
    "83.3%": "25.0%",
    "Inclusion": "Inclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 302199004",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient agreed to lumbar puncture for CSF biomarker analysis."
  },
  {
    "MMSE score between 22 and 30": "Stable medical condition for at least 3 months",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "41.7%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "SNOMED: 162607003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No significant changes in medication or clinical events in past 3 months."
  },
  {
    "MMSE score between 22 and 30": "No active CNS infection or demyelinating disease",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G04.90",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No evidence of CNS inflammation or multiple sclerosis."
  },
  {
    "MMSE score between 22 and 30": "Mini-Mental State Examination (MMSE) 18\u201326",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cognitive Assessment",
    "83.3%": "83.3%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 72107-6",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MMSE score at baseline was 23."
  },
  {
    "MMSE score between 22 and 30": "Diagnosis of probable Alzheimer's dementia per NIA-AA",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "91.7%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "SNOMED: 26929004",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Clinical diagnosis consistent with probable AD per NIA-AA guidelines."
  },
  {
    "MMSE score between 22 and 30": "Consent provided by patient or legally authorized representative",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 11341000146104",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Written informed consent signed by caregiver and patient."
  },
  {
    "MMSE score between 22 and 30": "Clinical Dementia Rating (CDR) global score 0.5\u20131.0",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Cognitive Assessment",
    "83.3%": "50.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 54829-9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "CDR global score of 0.5 confirmed during baseline screening."
  },
  {
    "MMSE score between 22 and 30": "Availability of amyloid PET scan or CSF biomarker confirmation",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 72509-4",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Amyloid PET scan positive for beta-amyloid deposition."
  },
  {
    "MMSE score between 22 and 30": "Geriatric Depression Scale (GDS) score \u2264 6",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Psychiatric Assessment",
    "83.3%": "33.3%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 44261-6",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient scored 4 on GDS\u2014within acceptable range for inclusion."
  },
  {
    "MMSE score between 22 and 30": "No major untreated sleep disorder",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G47.00",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No symptoms consistent with obstructive sleep apnea or insomnia."
  },
  {
    "MMSE score between 22 and 30": "No known autosomal dominant Alzheimer's mutations",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Genetic",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 94309-2",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No PSEN1, PSEN2, or APP mutations identified on genetic screening."
  },
  {
    "MMSE score between 22 and 30": "No enrollment in prior study with investigational anti-A\u03b2 therapy",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 763760008",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Not previously enrolled in any anti-amyloid beta antibody study."
  },
  {
    "MMSE score between 22 and 30": "Availability of caregiver to assist in study protocol",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Caregiver/Support",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "RelatedPerson",
    "LOINC: 72107-6": "SNOMED: 224291000000109",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Spouse committed to supporting patient through study procedures."
  },
  {
    "MMSE score between 22 and 30": "No participation in any prior lecanemab study",
    "Alzheimer's Disease": "Alzheimer's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "25.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 1087911000119102",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Subject confirmed to be lecanemab-na\u00efve."
  },
  {
    "MMSE score between 22 and 30": "Idiopathic Parkinson\u2019s disease diagnosis",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G20",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Diagnosed with idiopathic Parkinson\u2019s disease by neurologist."
  },
  {
    "MMSE score between 22 and 30": "Hoehn and Yahr stage \u2264 3",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "87.5%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 89049-5",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient assessed at Hoehn and Yahr stage 2.5."
  },
  {
    "MMSE score between 22 and 30": "Age \u2265 40 years",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Demographic",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "LOINC: 30525-0",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient is 61 years old\u2014meets age requirement."
  },
  {
    "MMSE score between 22 and 30": "On stable anti-parkinsonian medication regimen",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Medication History",
    "83.3%": "87.5%",
    "Inclusion": "Inclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 372729009",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient maintained on stable dose of carbidopa/levodopa for 2 months."
  },
  {
    "MMSE score between 22 and 30": "No history of brain surgery for Parkinson\u2019s",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "75.0%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 274025005",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No deep brain stimulation or lesioning procedures reported."
  },
  {
    "MMSE score between 22 and 30": "No atypical parkinsonism or secondary causes",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "87.5%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G21.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Evaluation ruled out drug-induced and vascular parkinsonism."
  },
  {
    "MMSE score between 22 and 30": "No significant cognitive impairment (MoCA \u2265 24)",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Cognitive Assessment",
    "83.3%": "75.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 72106-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MoCA score 26\u2014eligible for inclusion."
  },
  {
    "MMSE score between 22 and 30": "Able to give informed consent",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 11341000146104",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient signed informed consent form after discussion of study risks."
  },
  {
    "MMSE score between 22 and 30": "No major psychiatric disorder (e.g. schizophrenia, bipolar)",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "62.5%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F20.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No current or past diagnosis of schizophrenia or bipolar disorder."
  },
  {
    "MMSE score between 22 and 30": "No history of stroke or TIA",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I63.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient denies any past stroke or transient ischemic attacks."
  },
  {
    "MMSE score between 22 and 30": "Montreal Cognitive Assessment (MoCA) score available",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Cognitive Assessment",
    "83.3%": "62.5%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 72106-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MoCA score documented at 25 during baseline."
  },
  {
    "MMSE score between 22 and 30": "Stable medical conditions for at least 30 days",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "62.5%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "SNOMED: 162607003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No recent change in hypertension or diabetes medication in past month."
  },
  {
    "MMSE score between 22 and 30": "No unstable cardiovascular disease",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Cardiac/Vitals",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I51.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Cardiac evaluation indicates stable function; no recent angina or infarction."
  },
  {
    "MMSE score between 22 and 30": "No use of investigational drugs within 30 days",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "62.5%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient hasn\u2019t received any experimental therapy in last 2 months."
  },
  {
    "MMSE score between 22 and 30": "No severe depression or suicidality",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "62.5%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F33.2",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient screened negative for suicidal ideation and severe depressive symptoms."
  },
  {
    "MMSE score between 22 and 30": "No history of alcohol or drug abuse in past 12 months",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "62.5%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F10.10",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No alcohol or illicit drug use documented in the past year."
  },
  {
    "MMSE score between 22 and 30": "Able to comply with study protocol",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "75.0%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "SNOMED: 386053000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient demonstrated understanding of study schedule and procedures."
  },
  {
    "MMSE score between 22 and 30": "No MRI contraindications (e.g., pacemaker, metallic implants)",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Imaging",
    "83.3%": "62.5%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 433146000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Screening confirmed no metal implants or pacemaker; MRI approved."
  },
  {
    "MMSE score between 22 and 30": "No history of cancer in the past 5 years (except skin cancer)",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: Z85.09",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No history of malignancy except resolved basal cell carcinoma."
  },
  {
    "MMSE score between 22 and 30": "No use of antipsychotics or dopamine blockers within 6 months",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Medication History",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No recent exposure to risperidone, haloperidol, or similar agents."
  },
  {
    "MMSE score between 22 and 30": "Presence of caregiver or study partner",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Caregiver/Support",
    "83.3%": "62.5%",
    "Inclusion": "Inclusion",
    "Observation": "RelatedPerson",
    "LOINC: 72107-6": "SNOMED: 224291000000109",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Spouse confirmed as available and willing to assist with study visits."
  },
  {
    "MMSE score between 22 and 30": "Able to walk independently or with assistive device",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Functional Status",
    "83.3%": "50.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 16584000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient uses cane but ambulates independently at home and clinic."
  },
  {
    "MMSE score between 22 and 30": "No active infectious disease",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: B99.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No current symptoms or diagnosis of bacterial or viral infection."
  },
  {
    "MMSE score between 22 and 30": "No severe dyskinesia interfering with study procedures",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "37.5%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 42800007",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Dyskinesia mild and does not interfere with protocol assessments."
  },
  {
    "MMSE score between 22 and 30": "No participation in other interventional clinical trials",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "62.5%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 386053000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient not enrolled in any other active investigational study."
  },
  {
    "MMSE score between 22 and 30": "Negative pregnancy test (if applicable)",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "37.5%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2106-3",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Urine pregnancy test negative prior to randomization."
  },
  {
    "MMSE score between 22 and 30": "Willingness to use contraception during study",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "37.5%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 225426000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Participant agreed to use barrier contraception during trial period."
  },
  {
    "MMSE score between 22 and 30": "No history of psychosis",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F23.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No documented hallucinations or delusions in prior clinical history."
  },
  {
    "MMSE score between 22 and 30": "Body Mass Index (BMI) between 18 and 35 kg/m\u00b2",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Vitals",
    "83.3%": "25.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 39156-5",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "BMI calculated as 24.2 during physical exam\u2014eligible."
  },
  {
    "MMSE score between 22 and 30": "Adequate renal and hepatic function",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "50.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2160-0, 1920-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Creatinine and ALT/AST within normal reference range."
  },
  {
    "MMSE score between 22 and 30": "No unstable diabetes or uncontrolled hypertension",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I10, E11.65",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Blood pressure and glucose controlled on current regimen."
  },
  {
    "MMSE score between 22 and 30": "No diagnosis of dementia",
    "Alzheimer's Disease": "Parkinson's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "37.5%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F03.90",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient does not meet diagnostic criteria for dementia."
  },
  {
    "MMSE score between 22 and 30": "Diagnosis of epilepsy confirmed by EEG or clinical criteria",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G40.909",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Epilepsy diagnosis supported by abnormal EEG and seizure history."
  },
  {
    "MMSE score between 22 and 30": "Age \u2265 18 years",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Demographic",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "LOINC: 30525-0",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient is 26 years old\u2014eligible by age."
  },
  {
    "MMSE score between 22 and 30": "Minimum 2 seizures/month during baseline period",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Clinical",
    "83.3%": "85.7%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 313387002",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient reported 4 seizures in the last 30 days."
  },
  {
    "MMSE score between 22 and 30": "Stable dose of anti-epileptic drugs (AEDs) for \u2265 4 weeks",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Medication History",
    "83.3%": "85.7%",
    "Inclusion": "Inclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 372729009",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient maintained on stable dose of lamotrigine for past 5 weeks."
  },
  {
    "MMSE score between 22 and 30": "No history of non-epileptic seizures or psychogenic seizures",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "71.4%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: R56.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient evaluated for seizure type\u2014non-epileptic events ruled out."
  },
  {
    "MMSE score between 22 and 30": "Able to provide informed consent",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Administrative",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 11341000146104",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Written informed consent signed by patient after discussion of risks."
  },
  {
    "MMSE score between 22 and 30": "No history of status epilepticus in past 6 months",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "71.4%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G41.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No reported episodes of prolonged or continuous seizures in last 6 months."
  },
  {
    "MMSE score between 22 and 30": "No use of investigational drugs within 30 days",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "85.7%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No experimental therapy used by patient in the past month."
  },
  {
    "MMSE score between 22 and 30": "No history of progressive neurological disease (other than epilepsy)",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "71.4%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G31.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient has no evidence of neurodegenerative or progressive brain disorder."
  },
  {
    "MMSE score between 22 and 30": "Women of childbearing potential must use contraception",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Administrative",
    "83.3%": "57.1%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 225426000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Participant agrees to use hormonal or barrier contraception during study."
  },
  {
    "MMSE score between 22 and 30": "Negative urine or serum pregnancy test",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Lab",
    "83.3%": "57.1%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2106-3",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Baseline pregnancy screen returned negative."
  },
  {
    "MMSE score between 22 and 30": "No history of suicidal ideation or behavior (Columbia-Suicide Severity Rating Scale)",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "71.4%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 89279-5",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "CSSRS negative\u2014no suicidal thoughts or behaviors reported in last 6 months."
  },
  {
    "MMSE score between 22 and 30": "BMI within normal or acceptable range",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Vitals",
    "83.3%": "42.9%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 39156-5",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "BMI recorded as 23.1\u2014eligible for enrollment."
  },
  {
    "MMSE score between 22 and 30": "No history of major psychiatric illness (e.g., schizophrenia, bipolar disorder)",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "71.4%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F20.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient screened negative for any psychotic or bipolar disorder."
  },
  {
    "MMSE score between 22 and 30": "No known hypersensitivity to study drug or related compounds",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Allergy",
    "83.3%": "42.9%",
    "Inclusion": "Exclusion",
    "Observation": "AllergyIntolerance",
    "LOINC: 72107-6": "SNOMED: 419511003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No prior allergic reaction to sodium valproate or similar medications."
  },
  {
    "MMSE score between 22 and 30": "Adequate hepatic and renal function",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Lab",
    "83.3%": "71.4%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2160-0, 1920-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "ALT, AST, and creatinine all within normal limits."
  },
  {
    "MMSE score between 22 and 30": "No history of drug or alcohol abuse within past 12 months",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "57.1%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F10.10",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient denies alcohol or illicit substance use in past year."
  },
  {
    "MMSE score between 22 and 30": "Able to maintain seizure diary or have caregiver assistance",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Administrative",
    "83.3%": "57.1%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "SNOMED: 386053000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient and spouse willing to track seizures in diary daily."
  },
  {
    "MMSE score between 22 and 30": "No MRI contraindications (e.g., metal implants, pacemaker)",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Imaging",
    "83.3%": "42.9%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 433146000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No pacemaker or metallic implants\u2014MRI approved for subject."
  },
  {
    "MMSE score between 22 and 30": "No recent change in anti-epileptic drugs within 4 weeks",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Medication History",
    "83.3%": "57.1%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 372729009",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No dose adjustment to AED regimen in last 6 weeks."
  },
  {
    "MMSE score between 22 and 30": "Minimum 1-year history of epilepsy",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "42.9%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G40.909",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient first diagnosed with epilepsy at age 17, now 22 years old."
  },
  {
    "MMSE score between 22 and 30": "Not pregnant or breastfeeding",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Reproductive",
    "83.3%": "57.1%",
    "Inclusion": "Exclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 77386006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient not currently pregnant or nursing."
  },
  {
    "MMSE score between 22 and 30": "Able to attend scheduled study visits",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Administrative",
    "83.3%": "71.4%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "SNOMED: 386053000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient confirmed availability for all follow-up appointments."
  },
  {
    "MMSE score between 22 and 30": "No history of head trauma requiring hospitalization",
    "Alzheimer's Disease": "Epilepsy",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "42.9%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: S06.9X9A",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No prior admissions for traumatic brain injury."
  },
  {
    "MMSE score between 22 and 30": "Diagnosis of multiple sclerosis per McDonald criteria",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G35",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Diagnosed with relapsing MS based on 2017 McDonald criteria."
  },
  {
    "MMSE score between 22 and 30": "Expanded Disability Status Scale (EDSS) score 0 to 5.5",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Clinical",
    "83.3%": "84.6%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 72006-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "EDSS score recorded as 4.0 during screening."
  },
  {
    "MMSE score between 22 and 30": "At least 1 or 2 relapses in the past 1-2 years",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Clinical",
    "83.3%": "76.9%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 443585000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient had 2 documented relapses in the past 18 months."
  },
  {
    "MMSE score between 22 and 30": "Primary progressive MS diagnosis",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "30.8%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G35.1",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Classified as primary progressive MS on last neurology evaluation."
  },
  {
    "MMSE score between 22 and 30": "Secondary progressive MS without relapse",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "23.1%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G35.2",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Progressive disability over 12 months without clinical relapses."
  },
  {
    "MMSE score between 22 and 30": "Neurologic stability for \u226530 days prior to screening",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Clinical",
    "83.3%": "46.2%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 386661006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No worsening in neurologic exam over the last month."
  },
  {
    "MMSE score between 22 and 30": "Diagnosis duration limits based on EDSS",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Clinical",
    "83.3%": "61.5%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G35",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "MS duration exceeds 10 years with EDSS below 2.0 \u2013 not eligible."
  },
  {
    "MMSE score between 22 and 30": "No prior treatment with immunosuppressive monoclonal antibodies",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "69.2%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 372729009",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient never received rituximab or ocrelizumab previously."
  },
  {
    "MMSE score between 22 and 30": "Washout period from disease-modifying therapies (DMTs)",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "61.5%",
    "Inclusion": "Inclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Completed 30-day washout after stopping fingolimod."
  },
  {
    "MMSE score between 22 and 30": "Adequate hepatic and renal function",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Lab",
    "83.3%": "76.9%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2160-0, 1920-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "ALT, AST, creatinine all within normal ranges on screening labs."
  },
  {
    "MMSE score between 22 and 30": "No clinically significant cardiac history (e.g., arrhythmia, MI)",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "53.8%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: I49.9, I21.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No history of myocardial infarction or arrhythmias."
  },
  {
    "MMSE score between 22 and 30": "Negative pregnancy test for women of childbearing potential",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Lab",
    "83.3%": "69.2%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2106-3",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Urine beta-hCG test was negative on day of screening."
  },
  {
    "MMSE score between 22 and 30": "Use of effective contraception during study period",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Administrative",
    "83.3%": "69.2%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 225426000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient agreed to use two contraceptive methods for study duration."
  },
  {
    "MMSE score between 22 and 30": "No active infection (e.g., hepatitis, TB, HIV)",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "61.5%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: B99.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Negative screening labs for HIV, HBV, HCV, and TB."
  },
  {
    "MMSE score between 22 and 30": "No history of malignancy within past 5 years",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "46.2%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: Z85.9",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No cancer diagnosis or treatment reported in last 5 years."
  },
  {
    "MMSE score between 22 and 30": "No current use of investigational agents",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "53.8%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient is not enrolled in any other clinical trial currently."
  },
  {
    "MMSE score between 22 and 30": "Ability to provide informed consent",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Administrative",
    "83.3%": "92.3%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 11341000146104",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Subject signed informed consent after reviewing protocol with staff."
  },
  {
    "MMSE score between 22 and 30": "MRI eligibility (no contraindicated implants or devices)",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Imaging",
    "83.3%": "38.5%",
    "Inclusion": "Inclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 433146000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No pacemaker, aneurysm clips, or metal implants detected."
  },
  {
    "MMSE score between 22 and 30": "No history of severe allergic reactions or hypersensitivity",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Allergy",
    "83.3%": "38.5%",
    "Inclusion": "Exclusion",
    "Observation": "AllergyIntolerance",
    "LOINC: 72107-6": "SNOMED: 419511003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No history of anaphylaxis or hypersensitivity to biologic agents."
  },
  {
    "MMSE score between 22 and 30": "No severe psychiatric illness (e.g., psychosis, suicidal ideation)",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "46.2%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F20.9, R45.851",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No psychotic disorder, suicidal ideation, or hospitalizations for depression."
  },
  {
    "MMSE score between 22 and 30": "Ability to attend scheduled visits and comply with study protocol",
    "Alzheimer's Disease": "Multiple Sclerosis",
    "Cognitive Assessment": "Administrative",
    "83.3%": "84.6%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "SNOMED: 386053000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Subject confirmed ability to complete all protocol visits and assessments."
  },
  {
    "MMSE score between 22 and 30": "Diagnosis of definite or probable ALS per revised El Escorial criteria",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G12.21",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient meets El Escorial criteria for probable ALS."
  },
  {
    "MMSE score between 22 and 30": "Symptom onset within past 2 to 3 years",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Clinical",
    "83.3%": "87.5%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 248536006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Initial bulbar symptoms began approximately 20 months ago."
  },
  {
    "MMSE score between 22 and 30": "Age 18 to 75 years",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Demographic",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "LOINC: 30525-0",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient is 54 years old and meets the age requirement."
  },
  {
    "MMSE score between 22 and 30": "ALS Functional Rating Scale-Revised (ALSFRS-R) score \u2265 30",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Clinical",
    "83.3%": "75.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 89262-1",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "ALSFRS-R score was 34 at screening."
  },
  {
    "MMSE score between 22 and 30": "Slow vital capacity (SVC) \u2265 60% predicted",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Lab",
    "83.3%": "75.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 19870-5",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Baseline SVC measured 65% of predicted value."
  },
  {
    "MMSE score between 22 and 30": "Able to swallow oral medication",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Clinical",
    "83.3%": "62.5%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 26643006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient able to swallow tablets without difficulty."
  },
  {
    "MMSE score between 22 and 30": "Use of riluzole permitted if stable dose \u2265 30 days",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Medication History",
    "83.3%": "62.5%",
    "Inclusion": "Inclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Riluzole continued at 50 mg BID for last 2 months."
  },
  {
    "MMSE score between 22 and 30": "No gastrostomy tube (PEG) for feeding at screening",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Clinical",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 26643006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient feeds orally and does not use PEG tube."
  },
  {
    "MMSE score between 22 and 30": "No tracheostomy or use of invasive ventilation at baseline",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Clinical",
    "83.3%": "62.5%",
    "Inclusion": "Exclusion",
    "Observation": "Procedure",
    "LOINC: 72107-6": "SNOMED: 426933007",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient breathes unassisted and has no tracheostomy."
  },
  {
    "MMSE score between 22 and 30": "Women of childbearing potential must use effective contraception",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Administrative",
    "83.3%": "62.5%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 225426000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Subject agreed to use hormonal contraception for duration of study."
  },
  {
    "MMSE score between 22 and 30": "Negative pregnancy test before enrollment",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Lab",
    "83.3%": "62.5%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2106-3",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Serum pregnancy test was negative at screening."
  },
  {
    "MMSE score between 22 and 30": "Adequate liver and kidney function",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Lab",
    "83.3%": "75.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2160-0, 1920-8",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Liver enzymes and serum creatinine within normal limits."
  },
  {
    "MMSE score between 22 and 30": "No participation in another investigational drug trial within 30 days",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Not currently or recently enrolled in any other trial."
  },
  {
    "MMSE score between 22 and 30": "No history of other significant neurologic disorders (e.g., MS, PD)",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "50.0%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G35, G20",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient has no known history of Parkinson\u2019s or multiple sclerosis."
  },
  {
    "MMSE score between 22 and 30": "Willing and able to comply with all study procedures",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Administrative",
    "83.3%": "87.5%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "SNOMED: 386053000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Participant confirmed availability and willingness to attend all visits."
  },
  {
    "MMSE score between 22 and 30": "Able to provide informed consent",
    "Alzheimer's Disease": "ALS",
    "Cognitive Assessment": "Administrative",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 11341000146104",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient gave written informed consent before any study-related procedure."
  },
  {
    "MMSE score between 22 and 30": "Confirmed genetic diagnosis of Huntington\u2019s disease",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Genetic",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "ICD-10: G10",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient tested positive for expanded CAG repeat in HTT gene."
  },
  {
    "MMSE score between 22 and 30": "Age 18 to 65 years",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Demographic",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Patient",
    "LOINC: 72107-6": "LOINC: 30525-0",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient is 44 years old and meets age requirement."
  },
  {
    "MMSE score between 22 and 30": "Total Functional Capacity (TFC) score \u2265 7",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "88.9%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 702746003",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "TFC score assessed as 9 during screening visit."
  },
  {
    "MMSE score between 22 and 30": "Unified Huntington's Disease Rating Scale (UHDRS) motor score >5",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "77.8%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 89284-5",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "UHDRS motor exam total score recorded as 11."
  },
  {
    "MMSE score between 22 and 30": "Able to ambulate independently",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 284981008",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient can walk without assistive device."
  },
  {
    "MMSE score between 22 and 30": "Able to swallow oral medication",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Clinical",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "SNOMED: 26643006",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient able to take pills without difficulty."
  },
  {
    "MMSE score between 22 and 30": "Montreal Cognitive Assessment (MoCA) score \u2265 18",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Cognitive",
    "83.3%": "55.6%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 72",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": NaN
  },
  {
    "MMSE score between 22 and 30": "Willing and able to provide informed consent",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "100.0%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 11341000146104",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Subject signed informed consent before study procedures."
  },
  {
    "MMSE score between 22 and 30": "No history of other serious neurologic diseases (e.g., MS, PD)",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Diagnosis",
    "83.3%": "66.7%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: G35, G20",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Patient has no history of Parkinson\u2019s or multiple sclerosis."
  },
  {
    "MMSE score between 22 and 30": "No antipsychotic or investigational drug use within 30 days",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Treatment History",
    "83.3%": "77.8%",
    "Inclusion": "Exclusion",
    "Observation": "MedicationStatement",
    "LOINC: 72107-6": "SNOMED: 428181000124101",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No recent use of risperidone, haloperidol, or experimental drugs."
  },
  {
    "MMSE score between 22 and 30": "Women of childbearing potential must use effective contraception",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Administrative",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "Consent",
    "LOINC: 72107-6": "SNOMED: 225426000",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Participant agreed to use hormonal contraception during study."
  },
  {
    "MMSE score between 22 and 30": "Negative pregnancy test prior to enrollment",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "66.7%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 2106-3",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "Serum pregnancy test was negative on Day 0."
  },
  {
    "MMSE score between 22 and 30": "Adequate hepatic and renal function",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Lab",
    "83.3%": "77.8%",
    "Inclusion": "Inclusion",
    "Observation": "Observation",
    "LOINC: 72107-6": "LOINC: 1920-8, 2160-0",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "ALT, AST, and creatinine were within normal range."
  },
  {
    "MMSE score between 22 and 30": "No history of significant psychiatric illness (e.g., suicidal ideation)",
    "Alzheimer's Disease": "Huntington's Disease",
    "Cognitive Assessment": "Psychiatric History",
    "83.3%": "55.6%",
    "Inclusion": "Exclusion",
    "Observation": "Condition",
    "LOINC: 72107-6": "ICD-10: F32.2, R45.851",
    "Mini-Mental State Examination (MMSE) score was 24 at screening.": "No suicidal thoughts or psychiatric hospitalizations documented."
  }
]